跳至主要内容
临床试验/CTRI/2024/07/071525
CTRI/2024/07/071525尚未招募不适用

Analysis of Prescribing pattern and Adverse drug reactions of Anti-diabetic drugs in patients of Type 2 Diabetes Mellitus in a tertiary care teaching hospital - A prospective observational study.

Government Medical College, Jammu1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2024年8月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
250
试验地点
1
主要终点
PRIMARY OBJECTIVES

研究概览

简要总结

This study will be designed to analyse the pattern of anti-diabetic drugs prescribed to the patients. Details of patient related information such as demographic profile, prescribed drug, dose, route of administration, frequency of administration will be recorded on the patient information form. Other drug related information such as number of anti-diabetic drugs per prescription, drugs prescribed by generic name vs branded name, Mono therapy vs Combination therapy, number of anti diabetic drugs prescribed from National List of Essential Medicine (latest) and details of concomitant medications will also be recorded and analyzed.

The rationality of prescriptions will be assessed using the WHO

core prescribing indicators which include :

a)Average number of drugs prescribed.

b)Percentage of encounters with an antibiotic prescribed.

c)Percentage of encounters with an injection prescribed.

d)Percentage of drugs prescribed from National List of Essential Medicines (NLEM).

e)Percentage of drugs prescribed by generic names.

Patients on anti-diabetic drugs will also be screened for suspected Adverse Drug Reactions (ADRs). These ADRs will then be reported using Suspected Adverse Drug Reaction Reporting Form (version 1.4).

The causality assessment of the suspected ADR will be done using “WHO-Uppsala Monitoring Centre (WHO-UMC) causality assessment scale” which categorizes causality of an ADR into 6 categories: certain, probable, possible, unlikely, conditional/unclassified,unassessable/unclassified.

Severity of the ADRs will be assessed using “Modified Hartwig and Siegel Severity Assessment scale” which categorizes severity of ADR into 7 levels (Mild= level 1 and 2, moderate= level 3 and 4, severe= 5, 6 and 7).

Preventability of ADRs will be assessed by using “Modified Schumock and Thornton scale” which categorizes the preventability of an ADR into “Definitely preventable”, “probably preventable” and “not preventable”.

Statistical Analysis of the data will be done using Microsoft Excel and SPSS software. Categorical variables will be presented as numbers and percentages and quantitative variables as mean ± SD.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • INCLUSION CRITERIA
  • Patients of Type 2 Diabetes Mellitus attending Endocrinology OPD.
  • Patients of either sexes, aged 18 years and above.
  • Patients willing to give written informed consent.

排除标准

  • EXCLUSION CRITERIA
  • Patients diagnosed with Type 1 Diabetes Mellitus.
  • Pregnant and lactating patients.
  • Patients with malignancy.

结局指标

主要结局

PRIMARY OBJECTIVES

时间窗: Baseline

1. To study the prescribing pattern of anti-diabetic drugs in patients of

时间窗: Baseline

Type 2 Diabetes Mellitus.

时间窗: Baseline

2. To monitor the incidence and pattern of Adverse drug reactions due

时间窗: Baseline

to anti-diabetic drugs in patients of Type 2 Diabetes Mellitus.

时间窗: Baseline

次要结局

  • SECONDARY OBJECTIVES(1. To study the prescribing pattern of concomitant medications given)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Sheena Sethi

Government Medical College, Jammu

研究点 (1)

Loading locations...

相似试验